glp-1 vision Lipsitz, Ponterio & Comerford Vision loss: GLP-1 drugs like

More people discontinued orforglipron during the trial than those who stopped taking semaglutide, too. (Scientific American) Novo Nordisks semaglutide received FDA approval for an oral tablet for weight loss in January 2026 and reached over 26,000 prescriptions within two weeks of launch

This kind of team-based approach is exactly how we help patients manage inflammatory conditions and protect long-term health

Heres how it compares: Mechanism of Action: Unlike traditional diabetes medications such as metformin, which decreases glucose production in the liver, or insulin therapies that increase glucose uptake by the body's cells, empagliflozin works by blocking the reabsorption of glucose in the kidneys

Additionally, the altered gastrointestinal motility may affect the timing of food delivery to the small intestine where natural enzymes from the pancreas act

Clinicians can monitor HbA1c levels, weight changes, and glucose patterns within the first three to six months of treatment